CA2446562C - Formulation pharmaceutique de propionate de fluticasone - Google Patents

Formulation pharmaceutique de propionate de fluticasone Download PDF

Info

Publication number
CA2446562C
CA2446562C CA002446562A CA2446562A CA2446562C CA 2446562 C CA2446562 C CA 2446562C CA 002446562 A CA002446562 A CA 002446562A CA 2446562 A CA2446562 A CA 2446562A CA 2446562 C CA2446562 C CA 2446562C
Authority
CA
Canada
Prior art keywords
fluticasone propionate
formulation
ethanol
glycerol
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002446562A
Other languages
English (en)
Other versions
CA2446562A1 (fr
Inventor
Alan Leslie Cripps
Paul Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9921396.9A external-priority patent/GB9921396D0/en
Priority claimed from GB0014451A external-priority patent/GB0014451D0/en
Priority claimed from GB0018654A external-priority patent/GB0018654D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to CA002486805A priority Critical patent/CA2486805A1/fr
Priority claimed from CA002317999A external-priority patent/CA2317999C/fr
Publication of CA2446562A1 publication Critical patent/CA2446562A1/fr
Application granted granted Critical
Publication of CA2446562C publication Critical patent/CA2446562C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002446562A 1999-09-11 2000-09-11 Formulation pharmaceutique de propionate de fluticasone Expired - Fee Related CA2446562C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002486805A CA2486805A1 (fr) 1999-09-11 2000-09-11 Aerosol-doseur contenant une formulation pharmaceutique de propionate de fluticasone

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9921396.9 1999-09-11
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation
GB0014451.9 2000-06-13
GB0014451A GB0014451D0 (en) 2000-06-13 2000-06-13 Pharmaceutical formulation
GB0018654A GB0018654D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation
GB0018654.4 2000-07-28
CA002317999A CA2317999C (fr) 1999-09-11 2000-09-11 Formulation pharmaceutique de propionate de fluticasone

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002317999A Division CA2317999C (fr) 1999-09-11 2000-09-11 Formulation pharmaceutique de propionate de fluticasone

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002486805A Division CA2486805A1 (fr) 1999-09-11 2000-09-11 Aerosol-doseur contenant une formulation pharmaceutique de propionate de fluticasone

Publications (2)

Publication Number Publication Date
CA2446562A1 CA2446562A1 (fr) 2001-03-11
CA2446562C true CA2446562C (fr) 2005-03-08

Family

ID=30003854

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002446562A Expired - Fee Related CA2446562C (fr) 1999-09-11 2000-09-11 Formulation pharmaceutique de propionate de fluticasone

Country Status (1)

Country Link
CA (1) CA2446562C (fr)

Also Published As

Publication number Publication date
CA2446562A1 (fr) 2001-03-11

Similar Documents

Publication Publication Date Title
CA2317999C (fr) Formulation pharmaceutique de propionate de fluticasone
EP1248597B1 (fr) Formulation pharmaceutique en aerosol de salmeterol et de propionate de fluticasone
AU2003210370B2 (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
UA80695C2 (en) Pharmaceutical formulation containing 2(1h)-quinolinone derivative long-acting -agonists administered by pressurised metered dose inhalers and method for the preparation thereof
SK284430B6 (sk) Farmaceutický prostriedok na použitie v aerosólovom inhalátore, aerosólový inhalátor a spôsob plnenia aerosólového inhalátora
US8088362B2 (en) Salmeterol superfine formulation
JP2004515454A (ja) 気管支肺疾患の治療のためのグルココルチコイド薬物を含有する製剤
CA2446562C (fr) Formulation pharmaceutique de propionate de fluticasone
GB2392915A (en) Pharmaceutical formulation of fluticasone propionate
EP1231894B1 (fr) Formulations pharmaceutiques de salmeterol
US20050048001A1 (en) Pharmaceutical formulations of salmeterol
CA2486805A1 (fr) Aerosol-doseur contenant une formulation pharmaceutique de propionate de fluticasone
GB2385596A (en) Pharmaceutical formulation of fluticasone propionate
WO2002072067A2 (fr) Formulation aerosol pharmaceutique
AU774250B2 (en) Pharmaceutical aerosol composition
JP2004503505A (ja) 医薬用抗炎症エアゾール製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130911